Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home
  • Log in
  • My Cart

Advanced Search

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
Perspective

Prolonging healthy aging: Longevity vitamins and proteins

Bruce N. Ames
  1. aNutrition and Metabolism Center, Children’s Hospital Oakland Research Institute (CHORI), Oakland, CA 94609-1809

See allHide authors and affiliations

PNAS October 23, 2018 115 (43) 10836-10844; first published October 15, 2018; https://doi.org/10.1073/pnas.1809045115
Bruce N. Ames
aNutrition and Metabolism Center, Children’s Hospital Oakland Research Institute (CHORI), Oakland, CA 94609-1809
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bames@chori.org
  1. Edited by Cynthia Kenyon, Calico Labs, San Francisco, CA, and approved September 13, 2018 (received for review May 30, 2018)

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

Abstract

It is proposed that proteins/enzymes be classified into two classes according to their essentiality for immediate survival/reproduction and their function in long-term health: that is, survival proteins versus longevity proteins. As proposed by the triage theory, a modest deficiency of one of the nutrients/cofactors triggers a built-in rationing mechanism that favors the proteins needed for immediate survival and reproduction (survival proteins) while sacrificing those needed to protect against future damage (longevity proteins). Impairment of the function of longevity proteins results in an insidious acceleration of the risk of diseases associated with aging. I also propose that nutrients required for the function of longevity proteins constitute a class of vitamins that are here named “longevity vitamins.” I suggest that many such nutrients play a dual role for both survival and longevity. The evidence for classifying taurine as a conditional vitamin, and the following 10 compounds as putative longevity vitamins, is reviewed: the fungal antioxidant ergothioneine; the bacterial metabolites pyrroloquinoline quinone (PQQ) and queuine; and the plant antioxidant carotenoids lutein, zeaxanthin, lycopene, α- and β-carotene, β-cryptoxanthin, and the marine carotenoid astaxanthin. Because nutrient deficiencies are highly prevalent in the United States (and elsewhere), appropriate supplementation and/or an improved diet could reduce much of the consequent risk of chronic disease and premature aging.

  • vitamins
  • essential minerals
  • aging
  • nutrition

I propose that an optimal level of many of the known 30 vitamins and essential minerals/elements (V/M), plus that of 11 new putative vitamins described herein, is necessary for promoting healthy aging. The “triage theory” (1) had previously introduced the concept that proteins/enzymes that are sacrificed on a V/M shortage are necessary for supporting long-term health. This insight is being broadened here to classify also many V/M as necessary for supporting long-term health. I present evidence that the deficiency of many V/M specifically increases the risk of future disease and shortens the lifespan. Thus, I propose that such V/M be named “longevity vitamins,” and that proteins associated with them be named “longevity proteins.” Prolongation of healthy aging has not been generally understood as being related to V/M levels.

Deficiencies in Vitamins and Minerals

Approximately 30 V/M are cofactors necessary for metabolism to function properly and were discovered because severe dietary deficiencies were linked to serious adverse health effects. They include vitamins A, B1, B2, B6, B12, biotin, C, choline, D, E, folic acid, K, niacin, pantothenate; and minerals/elements calcium, chloride, chromium, cobalt, copper, iodine, iron, manganese, magnesium, molybdenum, phosphorus, potassium, selenium, sodium, sulfur, and zinc. Some additional important nutrients, the marine omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentanoic acid (EPA), are discussed here, although they are not known as vitamins. Nine essential dietary amino acids are also important for the synthesis of proteins and hormones (2) but will not be discussed. The abbreviated term V/M is used throughout this presentation because it refers to a coherent category of nutrients, although only a few minerals/elements are discussed.

Most of the world’s population—even in developed countries—consume many of the V/M at levels below those recommended (3, 4). Using as reference the estimated average requirement (EAR) values [the intake level for a nutrient at which the needs of half of the healthy population is adequate and half is inadequate (5, 6)], the following numbers are given as examples of the high percentages of the United States population ingesting V/M quantities below the EAR (including fortifications and supplements): vitamin D, 70%; vitamin E, 60%; magnesium, 45%; calcium, 38%; vitamin K, 35%; vitamin A, 34%; vitamin C, 25%; zinc, 8%; vitamin B6, 8%; folate, 8% (7). Intakes of the marine omega-3 fatty acids DHA and EPA are also remarkably low in the United States population; an EAR has not been set (8). A varied and balanced diet could provide enough V/M for a healthier and longer life. A diet containing much of its calories as refined foods and sugar is deficient in V/M and leads to an unhealthy and shorter life.

The association or causality between various diseases of aging and a number of V/M deficiencies is analyzed here by screening the literature and using as criteria clinical trials, epidemiology, Mendelian randomization studies, and biochemical and medical literature. A sampling of the literature covering the link of various diseases with V/M deficiencies is provided in SI Appendix, SI-1 Vitamin and Mineral Deficiences.

Triage Theory

The triage theory (1) provides a unifying rationale for why modest V/M deficiencies—insufficient to elicit overt symptoms of severe deficiency—might contribute significantly to the aging process and the diseases of aging. Briefly, the triage theory posits that a strategic rationing response has been selected through evolution, which ensures that when a moderate shortage of a V/M is encountered, the scarce V/M is preferentially retained by those V/M-dependent proteins/enzymes that are essential for survival and reproduction, such as proteins essential for early development and immediate survival (i.e., “survival proteins”). At the same time, proteins/enzymes needed for maintaining long-term health by preventing insidious damage are starved for that V/M and become increasingly inactive, thus leading to an increase in diseases of aging. A major aspect of degenerative aging is that the damage is insidious and clinically not obvious because it accumulates slowly over time and is apparent only later in life. The connection to V/M shortages is underappreciated.

This concept of triage has been buttressed by our analyses of vitamin K and the element selenium (9, 10). Vitamin K-dependent proteins could be categorized into those required for short-term survival (primarily blood-clotting functions) and those involved in long-term health. A similar triage rationing was found for selenium-dependent proteins (10). Recent human studies provide additional support for the triage theory with respect to vitamin K and selenium (SI Appendix, SI-2 Triage Theory). It is noteworthy that in both of these cases about half of the proteins are affected negatively by a V/M shortage, suggesting that a large price could be paid in terms of accelerated aging by such a shortage.

The mechanisms by which triage rationing occurs vary: for vitamin K the proteins are found in physically unconnected tissues. In the case of selenium the rationing is based on the use of two different transfer RNAs (tRNAs) controlled by a modified base in the tRNA. Thus, different mechanisms were adopted for the same ultimate outcome in these two examples, suggesting that they evolved independently.

Although the triage theory (1, 9, 10) was originally thought of as a cofactor-rationing system, upon further consideration it should be more broadly construed to include a larger variety of components that are not enzyme cofactors, but are still essential elements in triage rationing. The trading-off of metabolic resources to achieve a balance between somatic maintenance and reproductive fitness was proposed in an evolutionary theory of why we age (11). The triage theory provides a mechanism for achieving such a trade-off.

Rethinking Vitamins: Longevity Proteins and Vitamins

Vitamins and essential minerals are usually thought of as compounds crucial for survival or protection against severe ill health, as shown by their dramatic short-term effect upon removal from the diet; most are necessary for critical metabolic functions. The role of vitamins in healthy aging has been less appreciated. I am introducing two concepts inherent in the triage-rationing mechanism: longevity proteins and longevity vitamins.

Longevity Proteins and Survival Proteins.

Among the insights derived from the triage theory are the following concepts: (i) not all proteins/enzymes are affected equally by a V/M deficiency; (ii) not all V/M are exclusively needed for short-term survival; (iii) adequate V/M throughout life plays an important role in healthy aging. I propose that during triage rationing proteins that are sacrificed to allow for survival belong to a category with the specific function of protecting against diseases of aging. I propose to name them longevity proteins. In contrast, those needed for short-term survival and reproduction, and thus preferentially supplied with a V/M necessary for their function (besides being also necessary for later health) are referred to as “survival enzymes/proteins.” A fraction of the cofactor-requiring proteins that are subject to triage rationing are not technically enzymes (e.g., regulatory or structural proteins).

Longevity Vitamins.

A redefinition of vitamins emerges from the definition of longevity proteins: the concept that the dietary compounds needed for the function of longevity proteins belong to a special category—that is, longevity vitamins—the shortage of which result in damage that is cumulative and insidious. Thus, vitamins may be divided into two general categories: (i) supporting both survival and longevity proteins (as defined above), and thus subject to triage rationing; and (ii) supporting health without emphasis on early survival, but with their shortage leading continuously to accelerated aging, which may or may not be rationed (e.g., antioxidants, many of which are not protein cofactors). Some of those that are rationed may not involve interaction with a protein (e.g., carotenoids).

In addition, I propose that an important consequence of this insight is the likely existence of compounds that are needed only for longevity, and therefore are not essential for short-term survival. It is likely that dietary compounds that are not essential for survival and are used exclusively for protecting and improving healthy longevity would not yet have been recognized as V/M, because the effects of their deficiency would have been evident only in the form of insidious late damage. Evidence for 10 putative longevity vitamins is presented below.

Survival V/M That Are also Longevity V/M

Inherent in the triage theory is the concept that most V/M necessary for the proper function of longevity proteins/enzymes are also survival V/M, having been originally discovered as cofactors for survival proteins. Thus, these V/M have two effects: on short-term survival and on long-term health. Besides the examples of vitamin K and selenium as being both essential and longevity V/M, three additional examples of V/M that have both effects are vitamin D, marine omega-3 fatty acids (DHA/EPA), and magnesium. The levels of each of these are inadequate in a large percentage of the American population, and these deficiencies are a major contributor to unhealthy aging.

Vitamin D.

Vitamin D levels are inadequate in 70% of the United States population. Almost all dark-skinned people residing in northern latitudes are particularly deficient (12, 13). Vitamin D was long considered responsible only for protecting against rickets, but it has now been shown to be involved in a myriad of functions. A cholesterol derivative, 7-dehydro-cholesterol, is converted by UV light to a precursor of vitamin D steroid hormone. Then the final steroid hormone binds to a protein, the vitamin D receptor protein; the latter interacts with a 12-base regulatory sequence in vitamin D receptor-dependent genes and regulates them either in a positive or negative fashion (12, 13). About 2,700 such binding sites have been found in the human genome as interacting with the vitamin D receptor protein (14). Extensive evidence shows that vitamin D deficiency causes—or has been associated with—a large number of diseases that affect healthy aging, such as all-cause mortality, cancer, cardiovascular disease (CVD), diabetes, brain function, and so forth. Considering this high level of deficiency and the important implications of vitamin D interactions, it is particularly important to tune up metabolism (15) with respect to vitamin D. See SI Appendix, SI-3 Survival V/M That Are also Longevity V/M for the large literature on vitamin D clinical trials and Mendelian randomization studies.

Supplementation with vitamin D, which would prevent and relieve some of these problems, has been discouraged for two reasons: fear of toxicity (in older studies) and numerous inadequate clinical trials. Newer evidence on the effect of vitamin D on all-cause mortality supersedes these toxicity studies, concluding that there was no increased risk even when blood levels of 25(OH)D were as high as 100 ng/mL (16⇓–18).

The use of randomized clinical trials (RCTs) for studying the effect of nutrients, as opposed to drug trials, can be subject to misinterpretation unless the level of the nutrient is measured both before supplementation starts and at its end. This precaution is necessary because many of the subjects may not be deficient in the nutrient being tested and the amount supplemented may be insufficient to raise levels adequately. The absence of such measurements can lead to erroneous negative results, as shown for various RCTs for vitamin D (19) and as pointed out repeatedly in the nutrition literature (20⇓⇓⇓⇓⇓⇓⇓–28). Many conclusions, both in medical journals (e.g., refs. 29 and 30) and in books (e.g., ref. 31), that supplemental vitamins are ineffective in performing some function generally ascribed to them, should be taken skeptically if the RCT did not include measurements of the vitamin.

Thus, it is clear that vitamin D performs more than just its initially assigned function of maintaining bone health. It is important for a healthy long life, and thus it is a longevity vitamin.

Marine Omega-3 Fatty Acids, DHA and EPA.

The intake of these compounds is inadequate in most of the United States population (8). Low EPA and DHA levels in red blood cells were found to be associated with increased all-cause mortality in a study of 6,501 elderly women followed for 14.9 y (32). A metaanalysis reported that each 1% increase in plasma DHA/EPA was linked with a 20% decreased risk in all-cause mortality (33).

DHA/EPA are present in high levels in the central nervous system and are important for brain and retinal structure and function (34). In an RCT on first-episode schizophrenia patients, omega-3 fatty acids supplementation prevented cortical loss of gray matter thickness and promises a possible treatment for schizophrenia (35). The role of DHA in aging, Alzheimer, Parkinson, schizophrenia, bipolar, and depression have been recently reviewed (34).

Low blood levels of DHA/EPA were shown in a 5-y study to be associated with a faster rate of telomere shortening, a marker of cell aging (36). Supplemental fish oil (2.5 g/d) slowed telomere shortening and lowered biomarkers of oxidation in older adults (37). Daily supplemental DHA (2 g/d) increased the rate of clearance of amyloid plaques in people with mild cognitive impairment (38). DHA/EPA are important for vitamin D steroid hormone effectiveness (13). Evidence of their role in reducing the risk of heart disease has been obtained (39, 40). Linolenic acid (omega-3) is now considered an essential fatty acid, but it is still unclear whether it is just needed as a precursor of DHA/EPA, which are inefficiently made from it.

Magnesium.

Mg is present in the center of the chlorophyll molecule, with plants being a major dietary source, together with whole grains, nuts, and seeds (41). Mg deficiency affects about 45% of the United States population and has been associated with increased all-cause mortality, poor DNA repair capacity, increased risk of lung cancer and various other kinds of cancer, heart disease, telomere shortening, and risk of stroke (SI Appendix, SI-3 Survival V/M That Are also Longevity V/M).

A recent review on the subclinical effects of Mg deficiency makes the case that this deficiency is a principal driver of CVD, a worldwide underrecognized problem, and thus that it is a major public health crisis (42). Mg is required to convert vitamin D to its active steroid hormone form (43).

In conclusion, these three examples of V/M deficiencies, together with the vitamin K and selenium studies, provide considerable evidence that these compounds fit the definition of longevity V/M, as well as being essential for survival, and that optimizing their intake offers a way to lengthen healthy longevity.

Conditional Vitamins

A conditional vitamin is synthesized by the body, but not at a level that is sufficient to optimize metabolism.

Choline.

Choline was the first example of a conditional vitamin (44): only 11% of women achieve the recommended intake and the average intakes for the population are half to two-thirds of this recommendation (45); severe choline deficiency results in DNA strand breaks in rodents, alterations to epigenetic markers and histones, and affects brain development (46⇓–48).

Taurine (2-Aminoethanesulfonic Acid).

Taurine is another example of a conditional vitamin because it is synthesized by animals (including humans), but not in sufficient amounts. It has been shown to be important in preventing numerous health problems, such as CVD, brain function, diabetes, and mitochondrial diseases, as summarized below. Because of taurine’s extensive involvement in health problems that lead to long-term damage, it is proposed here that it is also a longevity vitamin.

The synthesis of taurine involves cysteine decarboxylation and sulfhydryl oxidation. The rate of its biosynthesis is species-dependent, with a low level in humans, compared with rodents (which led to the suggestion that supplementation might be beneficial) (49). It is located in the cytosol and in mitochondria and it is present in virtually all human tissues at millimolar concentrations; it is especially high in electrically excitable and secretory tissues and in platelets. A 70-kg human contains about 70 g of taurine (50). An excellent review of all of the earlier work on taurine is available in Huxtable (50). Most of taurine is acquired from the diet, mainly from fish and other seafood, seaweed, eggs, and dark-meat poultry (51).

Taurine is particularly important in the mitochondria, where it is present as 5-taurinomethyl-uridine in tRNA-leu and tRNA-trp, and as 5-taurinomethyl-2-thiouridine in tRNA-glu, tRNA-gln, and tRNA-lys. In all five tRNAs, it is located in the wobble position, where it functions to read accurately alternate codons in the mitochondrial genome (52). A taurine modification defect in mitochondrial tRNA is associated with the mitochondrial diseases MELAS (mitochondrial encephalopathy, encephalopathy, lactic acidosis, and stroke-like episodes) and MERRF (myoclonus epilepsy with ragged-red fibers) (52), suggesting causality, and also that a taurine deficiency could result in the same diseases. Because of the involvement of mitochondria in energy production, there has been much interest in taurine in sports medicine in humans with reference to exercise-induced fatigue and recovery, as has been reviewed previously (53). In addition, a strong case has been made that taurine is the main buffer in mitochondria (54) and that it moderates mitochondrial oxidant production (55).

Another possibly important function of taurine is its detoxification of chloramine (a very toxic membrane-soluble oxidant) via its conversion to taurine-chloramine (56, 57).

Examples of several important insidious long-term pathologies that taurine would protect against are: CVD, brain dysfunction, and diabetes. Taurine effects on CVD have been examined by numerous RCTs and have been reviewed previously (51). Taurine supplementation lowers blood pressure, improves vascular function, and raises plasma hydrogen sulfide levels as shown in a recent RCT with prehypertension patients (58). Taurine consumption was the most significant factor associated with reduced risk of ischemic heart disease (IHD) in two international epidemiological studies of CVD in 61 populations (25 countries; n = 14,000): Japanese people in Okinawa had the highest taurine dietary intake and the lowest incidence of IHD and longest lifespan. In contrast, Japanese immigrants in Brazil who eat little seafood, but more meat and salt, had a 17-y shorter lifespan as a consequence of a very high IHD mortality (59). Other human clinical studies showed that taurine decreases platelet aggregation, serum cholesterol levels, LDL/triglyceride levels, and enhances cardiac function (60).

Taurine plays an important role in brain development, including neuronal proliferation, stem cell proliferation, and differentiation; it has no toxic effects in humans (61). It is a neuromodulator in the central nervous system: it activates the GABA- and glycine-insensitive chloride channel and it inhibits the N-methyl-d-aspartate receptor. It is also neuroprotective and has a role in neural development and neurogenesis; it was shown in an RCT that symptoms of psychopathology were improved by its administration in patients with first-episode psychosis (62).

Diabetic remediation by taurine has been reviewed previously (63, 64). Its supplementation remediates diabetic pathologies, including retinopathy, neuropathy, nephropathy, cardiopathy, atherosclerosis, altered platelet aggregation, and endothelial dysfunction (65). In patients with type 1 and type 2 diabetes the taurine transporter is up-regulated in mononuclear blood cells, indicating that increased levels of taurine are sought by the cell (66, 67). In rats, taurine reduces oxidative stress caused by diabetes (68, 69).

Taurine is important for fetal development, because the human fetus cannot synthesize taurine, which is provided by the mother via the taurine transporter, and it is necessary for organ development and protects against development of type 2 diabetes (70). Therefore, taurine is also a survival vitamin. Transport of taurine (53) is required for normal development of numerous fetal tissues in several experimental animals. Taurine functions as an osmolyte; it was shown to be important in that respect in a variety of species, including rodent investigations that are consistent with the above results on humans (70, 71) (SI Appendix, SI-4 Conditional Vitamins).

Taurine is well established as an important conditional vitamin for survival functions and for healthy longevity in both humans and experimental animals. I expect that a large class of new conditional vitamins will be discovered. Possible candidates are lipoic acid, ubiquinone, and carnitine.

Putative Longevity Vitamins: Ergothionine, Pyrroloquinoline Quinone, Queuine, Carotenoids

I propose that many of the known vitamins and minerals have, besides a “survival” function, aging-delaying (“longevity”) functions as well. I also propose that other dietary biochemicals, not officially recognized as vitamins or as having age-delaying functions, have a positive age-delaying effect. Several such compounds are discussed as candidates for putative longevity vitamins: the fungal antioxidant ergothioneine (ESH); the bacterial compounds pyrroloquinoline quinone (PQQ) and queuine; and seven plant carotenoids. Among these putative longevity vitamins are specialized dietary antioxidants (ESH, PQQ, and carotenoids) that reduce the accumulation of long-term oxidative damage (besides other important functions) and are not normally classified as “survival vitamins.” It should be noted that within this category vitamin C is categorized as a survival vitamin because, in addition to being an antioxidant, it also functions as a cofactor for survival proteins. On the other hand, vitamin E is a fat-soluble, free-radical scavenger/chain-breaking antioxidant, and is not required for any known protein/enzyme functions. Neither are discussed further. Other important functions, besides protecting against oxidation, are associated with longevity. The mechanisms by which the body prevents insidious aging-related damage are likely to be numerous.

Ergothioneine.

ESH is present in the human diet. It is synthesized by most mushrooms (72), cyanobacteria, and many types of soil bacteria (73, 74), but not by plants or animals. Various plant foods contain small amounts of ESH taken up from the soil; animals that eat such plants contain ESH in their flesh. The edible fungi synthesize ESH to concentrations varying from a very high level (>100 mg/kg wet weight in oyster and king boletus mushrooms) to a much lower level (0.5 mg/kg) in the white-button commercial mushrooms, which is most commonly eaten. A detailed analysis suggests that mushrooms are a major ESH source in Europe (75). Foods known to have moderate levels of ESH (1 mg/kg wet weight) include beef, pork, lamb, and chicken. Oat bran, black turtle bean, and red kidney bean contain >3 mg/kg (72, 76).

ESH has been shown to be present in almost all human cell and tissue types, often at millimolar levels in the brain, bone marrow, lens and cornea of the eye, and erythrocytes (77, 78), where it appears to play a significant role as an antioxidant. Its function as a specialized antioxidant is thought to be implicated in CVD prevention and its redox chemistry has been reviewed previously (79, 80). Its levels decrease significantly with age past 80 y, and significantly lower levels were found in individuals with mild cognitive impairment (81). It has been suggested that ESH acts as an adaptive antioxidant for the protection of injured tissues (82). Rheumatoid arthritis has been associated with increased ESH levels in red blood cells in a case-controlled study (83). It is also present in high concentrations in mitochondria, a major source of oxidants, and it has been suggested that it may be a vitamin (84).

ESH in mammals is taken up by a specialized transporter, OCTN1 protein (85, 86), which appears to have been selected for in the European transition from hunter-gatherers to agriculturalists (87). Lack of this transporter results in oxidative damage to proteins, lipids, and DNA, and higher levels of mortality in human cells (84). Dysfunctional haplotypes of the ESH transporter gene are associated with Crohn’s disease (88, 89). The ESH transporter is essential because deletion of its gene in mice (90) or zebra fish (91) results in oxidative damage to DNA and lipids. All of these characteristics suggest an involvement in healthy aging. A likely mechanism of ESH action appears in SI Appendix, SI-5 Putative Longevity Vitamins.

The presence of ESH in human tissues, the essentiality of its transport system, its possible involvement in CVD prevention, its antioxidant, and cytoprotectant activities, all suggest that ESH is a putative longevity vitamin.

Pyrroloquinoline Quinone.

PQQ is made by many species of bacteria, but not by animals or plants. It is a cofactor for several bacterial dehydrogenases, such as glucose and methanol dehydrogenases (92, 93). It is synthesized by soil bacteria, enters plants from the soil (94), and thus enters human diets; it was detected in every sample of fruits and vegetables tested at levels 5–10 times higher than in human tissues and fluids. PQQ is an important plant growth factor imported from rhizobacteria (95). It is a powerful antioxidant and is much more stable than ascorbic acid; in redox cycling, PQQ has 20,000 potential catalytic cycles, compared with 4 for ascorbic acid (92).

The health benefits of PQQ in humans have been reviewed recently, including for diabetes, antioxidant activity, neuroprotection, cognition (96), and lowering the level of C-reactive protein (i.e., inflammation). In addition, PQQ supplementation improved antioxidant potential and decreased the levels of mitochondrial-related intermediates and metabolites in urine, providing support for previous studies that demonstrated that PQQ improved mitochondrial efficiency (97).

PQQ has been repeatedly suggested to be a vitamin, although arguments have been raised against it (92). The case for its being classified as a vitamin has become stronger due to a recent breakthrough study (98) of five mouse proteins that bind PQQ. This work confirmed that the activity of at least one mammalian enzyme, rabbit lactic dehydrogenase-A, depends on PQQ to catalyze the key conversion of lactate to pyruvate at physiological PQQ levels (98). This activity enables mitochondria, when limited in activity by reductive stress (i.e., high NADH/NAD ratio), to synthesize more ATP as an alternative to exporting lactate. PQQ has also been shown to induce mitochondrial biogenesis at low physiological levels (∼250 μg/kg in rat) through the proliferator-activated receptor-γ coactivator-1 α (PGC-1α) in peroxisomes (99, 100). Experiments in cats and rodents on PQQ are numerous and confirmatory (SI Appendix, SI-5 Putative Longevity Vitamins).

PQQ is promising as a longevity vitamin in humans. It is necessary for mitochondrial health (although most of the evidence for the latter comes from rodent studies).

Queuine.

Queuine is an evolutionarily ancient compound (101). It is a 7-deazaguanine derivative present in bacteria, which are unique in their ability to synthesize it and pass it on to plants and animals (102). Detectable amounts of queuine have been identified in tomatoes, wheat, coconut water, and milk from humans, cows, and goats (102). Humans and mice recover queuine from either ingested food or the gut flora. All eukaryotic organisms, including humans, convert queuine to queuosine by placing it in the wobble position (anticodon) of several tRNAs: aspartic acid, asparagine, histidine, and tyrosine (101, 103, 104). For details, see SI Appendix, SI-5 Putative Longevity Vitamins.

Queuine deficiency, uptake, and function have been reviewed (102). It is notable that eukaryotes have retained a number of dedicated proteins for queuine utilization, which include a conserved mitochondrial tRNA transglycosylase, thus indicating its essentiality (105). The cellular uptake of queuine appears to occur through a dedicated transporter (102). Queuine deficiency in human cells in vitro and in animals results in a reduced level of the cofactor tetrahydrobiopterin, BH4 (106). BH4 is a necessary cofactor for the conversion of phenylalanine to tyrosine, of tryptophan to serotonin, of tyrosine to DOPA (which gets converted into epinephrine and norepinephrine), of arginine to NO, and for the oxidation of alkyl glycerol lipids (107, 108). The essentiality of BH4 for the hydroxylation of tryptophan to produce serotonin could be of relevance to numerous neurological conditions, especially considering serotonin’s role as a social hormone controlling executive function, and its relevance to autism, attention deficit/hyperactivity disorder, bipolar, and schizophrenia (12, 13, 109⇓–111). Queuine-deficient mice become tyrosine-deficient, dying within 18 d of its withdrawal (112), despite the fact that tyrosine is a nonessential amino acid, presumably because it results in BH4 deficiency.

A recent key paper (113) shows that queuine and a synthetic analog have been proven effective in a mouse model of multiple sclerosis in eliciting full remission from the disease. Animals deficient in the tRNA guanine transglycosylase, and thereby incapable of modifying tRNA, fail to respond to therapy, implying that modulation of protein translation is the principal means through which the therapeutic effect is elicited.

The finding that queuine is located in the wobble position of tRNA (an ancient molecule), that a number of dedicated enzymes for queuine utilization have been strongly conserved in eukaryotes, the existence of a dedicated transporter, the effect on BH4 synthesis, together with its broad distribution, all suggest that queuine should be classified as a putative longevity vitamin. It will be desirable to obtain evidence of human pathologies, and thus of unhealthy aging, consequent to a lack of queuine.

Carotenoids.

There are ∼600 carotenoids synthesized by plants, but not by animals. They act as antioxidant pigments in all plants and usually contain 11 conjugated double bonds, which accounts for their yellow/orange/red colors. All photosynthetic plants synthesize carotenoids to quench singlet oxygen, a highly energetic and toxic form of oxygen created in cells by strong light. The toxicity of singlet oxygen is due to its ability to oxidize proteins, lipids, and nucleic acids, which can lead to cell death (114). The extra singlet oxygen energy is dissipated as heat via the long chain of conjugated double bonds in these compounds. They mimic enzymes in that one molecule of carotenoid can destroy hundreds of molecules of singlet oxygen. It should be noted that because the carotenoid family is very large, carotenoids related to each other may replace each other to perform the same functions, depending on the individual diet.

The following six carotenoids account for 95% of the carotenoids found in American blood and brain: lutein, zeaxanthin, lycopene, α- and β-carotene, and β-cryptoxanthin. The importance for health of a seventh carotenoid, the powerful marine carotenoid astaxanthin, which contains 13 conjugated double bonds, is also discussed (SI Appendix, SI-5 Putative Longevity Vitamins). These are increasingly being accepted as vitamin-like nutrients (115). There is good evidence that these carotenoids help optimize a healthy lifespan: low intake of these carotenoids has been associated with all-cause mortality, macular degeneration and associated blindness, cognitive decline, CVD, various types of cancer, metabolic syndrome, oxidative damage to DNA, high blood pressure, hearing loss, decreased visual acuity, inflammation, immune decay, and cognitive decay. It is well known that α- and β-carotene, and β-cryptoxanthin are precursors of vitamin A; thus, some of the health effects upon their deficiency may be due to insufficient vitamin A. A description of their chemical nature and properties, together with a summary of the analysis of their link to diseases of aging, appears in SI Appendix, SI-5 Putative Longevity Vitamins.

Carotenoids are included among putative longevity vitamins because of the evidence that they protect long-term health. The strength of the evidence varies, but they deserve more attention for their role for achieving a healthy longevity.

Discussion

Prolonging good health while aging is an important issue in a world with large increases in life expectancy. Mechanistic, genetic, and epidemiological evidence suggests that the metabolic trade-off occurring upon a V/M shortage results in an accumulation of insidious damage and aging-associated diseases. Here I propose that the relatively simple approach of securing sufficient intake of well-known dietary V/M, plus taurine, plus the 10 putative longevity vitamins introduced here, could lead to healthy aging by “tuning-up metabolism” (15) and promoting metabolic harmony and health. Other important nutrients will undoubtedly be found in the future. Because about one-quarter of enzymes require 1 of the ∼30 survival and longevity V/M as a cofactor in complex metabolic networks (116), it is clearly important that the organism be properly supplied with such compounds. By optimizing survival and longevity V/M intake throughout life, premature, insidious, and increased risk of degenerative diseases may in large part be preventable.

V/M deficiencies, as indicated by intakes below the EAR, are common in the United States (6, 7, 117) and around the globe, especially among the poor, children, adolescents, the obese, and the elderly. According to the official National Academy of Medicine measure of inadequacy, most of the United States population is below the EAR for one or more essential V/M. It should be noted that the official definition of EAR does not take into consideration that the “healthy” population sampled may be only “apparently healthy” because evidence is provided herein that it is actually aging faster due to long-term triage effects. Therefore, official EAR values might actually have been set too low, because they did not take long-term triage effects into account, and thus more people would be erroneously considered “adequate.” Thus, a concept derived from this proposal is that EAR values should be set for longevity V/M by taking into account long-term effects of longevity V/M.

Evidence is accumulating that lack of foods that are particularly nutrient-rich is a contributor to diseases of aging. “Healthy foods” are nutrient-dense, containing high levels of V/M, fiber, and longevity vitamins, relative to calories (5): for example, nuts/seeds, eggs, seafood, vegetables, and fruits (118⇓–120). These foods are enriched in vitamins to nourish the next generation. Humans should be able to stay healthier longer during old age if nourished appropriately. It is important to link a mechanistic understanding of the diseases of aging to the consumption of individual nutrients and to their synergies (121, 122).

Our emphasis on insidious damage does not imply that V/M deficiency is the only major cause of the degenerative diseases of aging. For example, many types of cancers, dementias, and other degenerative diseases may be caused by pathogens (123) or genetics. However, V/M intervention might also help prevent some of these, as for example, by protecting the immune system (124), which defends against pathogens in elderly individuals.

Although V/M are generally understood to be important for health, it is not usually understood that other substances—usually referred to as micronutrients, bioactives, and so forth—are equally important for health, although not resulting in acute signs upon deficiency. Thus, I propose to call these compounds, collectively, longevity vitamins, in the interest of clarity and public health.

Some of the insidious damage due to a nutrient shortage may be reversible once the V/M intake is increased. However, some insidious damage would not be reversible if it were due to a mutational event, such as loss of a chromosome (e.g., in the case of vitamin K deficiency, as mimicked by TGFβI inactivation) or, as in the case of DNA damage, resulting from mutagenic oxidant release consequent to shortage of the antioxidant selenium.

Obese individuals are paricularly deficient in V/M (125⇓⇓⇓⇓–130), which is a likely explanation, among others, for a decrease in longevity through an increased frequency of every age-associated disease that has been examined, including cancer (131), heart disease (132⇓–134), brain decay (135⇓–137), and immune decay (138). The health and longevity of the obese would benefit greatly from an improvement in their V/M intake.

It should be noted that plants contain a large number of bioactive chemicals, which are present in our diets, as for example 8,000 different flavonoids (139). Flavonoids function as “nature’s pesticides,” the purpose of which is to protect plants from predators (140); many have beneficial (or toxic) effects in humans at some dose and may function by inducing hormetic mechanisms (141). There is no evidence, to my knowledge, that these compounds act as vitamins.

The involvement of tRNA-modified bases in triage rationing in the cases of selenium (10) and of taurine and queuine provides three examples of such a mechanism of rationing. The use of tRNA-modified bases suggests that this is an ancient mechanism dating to the RNA world that presumably preceded the DNA world (142) and may involve many aspects of metabolism.

An important concept relative to the use of vitamins for health is the fact that over 50 human genetic diseases can be ameliorated by the administration of high doses of supplements (143). Supplementation raises the concentration of the needed coenzyme to levels that overcome a defect in the enzyme-binding site (which is likely to be deformed by mutation or aging-related membrane rigidity) (144), besides possibly affecting the abundance and stability of some proteins. Some of the mitochondrial decay accompanying aging may be due to membrane rigidity and be remediable, as shown in rats (145). The remediation of proteins deformed by mutation or aging provides a simple way to improve health and longevity (144).

The Future

Eventually, the age of preventive medicine will take into consideration the major effects of V/M components, in addition to genetic factors. The optimization of the nutritional status and of the level of various biomarkers could be determined by each individual, perhaps through an analyzer machine using a finger-prick of blood (146). There is a need for the development of assays providing a range of the V/M levels required to keep enzymes/proteins optimally functional. Assays are also needed for the connection of deficiencies of longevity vitamins with their consequent respective pathologies. Measurements of the activity of longevity proteins are essential for detection of the functional effects of a low intake of each V/M. Two examples of consequences of V/M insufficiency, which are measurable, are increased DNA damage and mitochondrial decay. Understanding the full spectrum of longevity V/M will be augmented in future years.

The prevention of the degenerative diseases of aging is a different science than curing disease: it involves expertise in metabolism, nutrition, biochemistry, and genetic regulatory elements and polymorphisms. This approach is critical for lowering medical costs: it has been estimated that the European Union would save €4 billion from osteoporosis alone, by using vitamin D and calcium supplementation (147). The additional benefits derived from an improved V/M utilization would increase savings.

In conclusion, in addition to keeping physically fit, the low-hanging fruit in prolonging a healthy aging lies in optimizing V/M intake (e.g., refs. 12, 13, 15, 130, and 148).

Acknowledgments

I thank G. Ferro-Luzzi Ames, J. B. Blumberg, W. B. Grant, E. J. Johnson, V. P. Kelly, J. C. King, R. M. Krauss, J. C. McCann, R. P. Patrick, M. Profet, R. B. Rucker, J.-P. SanGiovanni, W. C. Willett, and S. H. Zeisel for their suggestions.

Footnotes

  • ↵1Email: bames{at}chori.org.
  • Author contributions: B.N.A. wrote the paper.

  • The author declares no conflict of interest.

  • This article is a PNAS Direct Submission.

  • This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809045115/-/DCSupplemental.

Published under the PNAS license.

References

  1. ↵
    1. Ames BN
    (2006) Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc Natl Acad Sci USA 103:17589–17594.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Hou Y,
    2. Wu G
    (2017) Nutritionally nonessential amino acids: A misnomer in nutritional sciences. Adv Nutr 8:137–139.
    OpenUrlFREE Full Text
  3. ↵
    1. Allen LH,
    2. de Benoist B,
    3. Dary O,
    4. Hurrell RF
    (2006) Guidelines on Food Fortification with Micronutrients (WHO, Geneva).
  4. ↵
    1. Mathias MG, et al.
    (2018) Clinical and vitamin response to a short-term multi-micronutrient intervention in brazilian children and teens: From population data to interindividual responses. Mol Nutr Food Res 62:e1700613.
    OpenUrl
  5. ↵
    1. Drewnowski A,
    2. Fulgoni VL 3rd
    (2014) Nutrient density: Principles and evaluation tools. Am J Clin Nutr 99(Suppl):1223S–1228S.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Blumberg JB,
    2. Frei B,
    3. Fulgoni VL 3rd,
    4. Weaver CM,
    5. Zeisel SH
    (2016) Vitamin and mineral intake is inadequate for most Americans: What should we advise patients about supplements? J Fam Pract 65(Suppl 9):S1–S8.
    OpenUrl
  7. ↵
    1. Fulgoni VL 3rd,
    2. Keast DR,
    3. Bailey RL,
    4. Dwyer J
    (2011) Foods, fortificants, and supplements: Where do Americans get their nutrients? J Nutr 141:1847–1854.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Papanikolaou Y,
    2. Brooks J,
    3. Reider C,
    4. Fulgoni VL 3rd
    (2014) U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: Results of an analysis using observational data from NHANES 2003-2008. Nutr J 13:31.
    OpenUrlCrossRefPubMed
  9. ↵
    1. McCann JC,
    2. Ames BN
    (2009) Vitamin K, an example of triage theory: Is micronutrient inadequacy linked to diseases of aging? Am J Clin Nutr 90:889–907.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. McCann JC,
    2. Ames BN
    (2011) Adaptive dysfunction of selenoproteins from the perspective of the triage theory: Why modest selenium deficiency may increase risk of diseases of aging. FASEB J 25:1793–1814.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Kirkwood TB,
    2. Austad SN
    (2000) Why do we age? Nature 408:233–238.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Patrick RP,
    2. Ames BN
    (2014) Vitamin D hormone regulates serotonin synthesis. Part 1: Relevance for autism. FASEB J 28:2398–2413.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Patrick RP,
    2. Ames BN
    (2015) Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: Relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J 29:2207–2222.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Ramagopalan SV, et al.
    (2010) A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution. Genome Res 20:1352–1360.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Ames BN
    (2003) The metabolic tune-up: Metabolic harmony and disease prevention. J Nutr 133(Suppl 1):1544S–1548S.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Ekwaru JP,
    2. Zwicker JD,
    3. Holick MF,
    4. Giovannucci E,
    5. Veugelers PJ
    (2014) The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One 9:e111265.
    OpenUrl
  17. ↵
    1. Grant WB, et al.
    (2016) Do studies reporting ‘U’-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects? Dermatoendocrinol 8:e1187349.
    OpenUrl
  18. ↵
    1. Kojima G,
    2. Iliffe S,
    3. Tanabe M
    (2017) Vitamin D supplementation as a potential cause of U-shaped associations between vitamin D levels and negative health outcomes: A decision tree analysis for risk of frailty. BMC Geriatr 17:236.
    OpenUrl
  19. ↵
    1. Veloudi P,
    2. Jones G,
    3. Sharman JE
    (2017) Effectiveness of vitamin D supplementation for cardiovascular health outcomes. Pulse (Basel) 4:193–207.
    OpenUrl
  20. ↵
    1. Blumberg J, et al.
    (2010) Evidence-based criteria in the nutritional context. Nutr Rev 68:478–484.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Michels AJ,
    2. Frei B
    (2013) Myths, artifacts, and fatal flaws: Identifying limitations and opportunities in vitamin C research. Nutrients 5:5161–5192.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Heaney RP
    (2014) Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev 72:48–54.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Smith GD,
    2. Wimalawansa SJ
    (2015) Reconciling the irreconcilable: Micronutrients in clinical nutrition and public health. Vitam Miner 4:e136.
    OpenUrl
  24. ↵
    1. Zeisel SH
    (2015) How nutrigenetics can help prove that nutrient-based interventions reduce disease risk. Sight Life 29:60–63.
    OpenUrl
  25. ↵
    1. Brenner H,
    2. Jansen L,
    3. Saum KU,
    4. Holleczek B,
    5. Schöttker B
    (2017) Vitamin D supplementation trials aimed at reducing mortality have much higher power when focusing on people with low serum 25-hydroxyvitamin D concentrations. J Nutr 147:1325–1333.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Grant WB,
    2. Boucher BJ,
    3. Bhattoa HP,
    4. Lahore H
    (2017) Why vitamin D clinical trials should be based on 25-hydroxyvitamin D concentrations. J Steroid Biochem Mol Biol 177:266–269.
    OpenUrl
  27. ↵
    1. Wagner CL,
    2. Hollis BW,
    3. Kotsa K,
    4. Fakhoury H,
    5. Karras SN
    (2017) Vitamin D administration during pregnancy as prevention for pregnancy, neonatal and postnatal complications. Rev Endocr Metab Disord 18:307–322.
    OpenUrl
  28. ↵
    1. Scragg R
    (2017) Limitations of vitamin D supplementation trials: Why observational studies will continue to help determine the role of vitamin D in health. J Steroid Biochem Mol Biol 177:6–9.
    OpenUrl
  29. ↵
    1. Guallar E,
    2. Stranges S,
    3. Mulrow C,
    4. Appel LJ,
    5. Miller ER 3rd
    (2013) Enough is enough: Stop wasting money on vitamin and mineral supplements. Ann Intern Med 159:850–851.
    OpenUrlPubMed
  30. ↵
    1. Autier P,
    2. Boniol M,
    3. Pizot C,
    4. Mullie P
    (2014) Vitamin D status and ill health: A systematic review. Lancet Diabetes Endocrinol 2:76–89.
    OpenUrl
  31. ↵
    1. Offit PA
    (2013) Do You Believe in Magic? The Sense and Nonsense of Alternative Medicine (HarperCollins, New York).
  32. ↵
    1. Harris WS, et al.
    (2017) Red blood cell polyunsaturated fatty acids and mortality in the Women’s Health Initiative Memory Study. J Clin Lipidol 11:250–259.e5.
    OpenUrl
  33. ↵
    1. Chen GC,
    2. Yang J,
    3. Eggersdorfer M,
    4. Zhang W,
    5. Qin LQ
    (2016) N-3 long-chain polyunsaturated fatty acids and risk of all-cause mortality among general populations: A meta-analysis. Sci Rep 6:28165.
    OpenUrl
  34. ↵
    1. Lacombe RJS,
    2. Chouinard-Watkins R,
    3. Bazinet RP
    (February 9, 2018) Brain docosahexaenoic acid uptake and metabolism. Mol Aspects Med doi:10.1016/j.mam.2017.12.004.
    OpenUrlCrossRef
  35. ↵
    1. Pawelczyk T, et al.
    (2017) Omega-3 fatty acid supplementation may prevent loss of gray matter thickness in the left parieto-occipital cortex in first episode schizophrenia: A secondary outcome analysis of the OFFER randomized controlled study. Schizophr Res 195:168–175.
    OpenUrl
  36. ↵
    1. Farzaneh-Far R, et al.
    (2010) Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA 303:250–257.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Kiecolt-Glaser JK, et al.
    (2013) Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: A randomized controlled trial. Brain Behav Immun 28:16–24.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Fiala M, et al.
    (2015) ω-3 supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J 29:2681–2689.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Alexander DD,
    2. Miller PE,
    3. Van Elswyk ME,
    4. Kuratko CN,
    5. Bylsma LC
    (2017) A meta-analysis of randomized controlled trials and prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and coronary heart disease risk. Mayo Clin Proc 92:15–29.
    OpenUrlCrossRefPubMed
  40. ↵
    1. O’Keefe JH,
    2. Jacob D,
    3. Lavie CJ
    (2017) Omega-3 fatty acid therapy: The tide turns for a fish story. Mayo Clin Proc 92:1–3.
    OpenUrl
  41. ↵
    1. Mahabir S, et al.
    (2008) Dietary magnesium and DNA repair capacity as risk factors for lung cancer. Carcinogenesis 29:949–956.
    OpenUrlCrossRefPubMed
  42. ↵
    1. DiNicolantonio J,
    2. O’Keefe J,
    3. Wilson W
    (2018) Subclinical magnesium deficiency: A principle driver of cardiovascular disease and a publice health crisis. Open Heart 5:1–16.
    OpenUrl
  43. ↵
    1. Rosanoff A,
    2. Dai Q,
    3. Shapses SA
    (2016) Essential nutrient interactions: Does low or suboptimal magnesium status interact with vitamin D and/or calcium status? Adv Nutr 7:25–43.
    OpenUrlAbstract/FREE Full Text
  44. ↵
    1. Zeisel S
    (2017) Choline, other methyl-donors and epigenetics. Nutrients 9:E445.
    OpenUrl
  45. ↵
    1. Wallace TC,
    2. Fulgoni VL 3rd
    (2016) Assessment of total choline intakes in the United States. J Am Coll Nutr 35:108–112.
    OpenUrl
  46. ↵
    1. Zeisel SH
    (2006) The fetal origins of memory: The role of dietary choline in optimal brain development. J Pediatr 149(Suppl):S131–S136.
    OpenUrlCrossRefPubMed
  47. ↵
    1. Zeisel SH
    (2012) Diet-gene interactions underlie metabolic individuality and influence brain development: Implications for clinical practice derived from studies on choline metabolism. Ann Nutr Metab 60:19–25.
    OpenUrlCrossRefPubMed
  48. ↵
    1. Zeisel SH
    (2012) Dietary choline deficiency causes DNA strand breaks and alters epigenetic marks on DNA and histones. Mutat Res 733:34–38.
    OpenUrlCrossRefPubMed
  49. ↵
    1. Bouckenooghe T,
    2. Remacle C,
    3. Reusens B
    (2006) Is taurine a functional nutrient? Curr Opin Clin Nutr Metab Care 9:728–733.
    OpenUrlCrossRefPubMed
  50. ↵
    1. Huxtable RJ
    (1992) Physiological actions of taurine. Physiol Rev 72:101–163.
    OpenUrlCrossRefPubMed
  51. ↵
    1. Wójcik OP,
    2. Koenig KL,
    3. Zeleniuch-Jacquotte A,
    4. Costa M,
    5. Chen Y
    (2010) The potential protective effects of taurine on coronary heart disease. Atherosclerosis 208:19–25.
    OpenUrlCrossRefPubMed
  52. ↵
    1. Suzuki T,
    2. Nagao A,
    3. Suzuki T
    (2011) Human mitochondrial diseases caused by lack of taurine modification in mitochondrial tRNAs. Wiley Interdiscip Rev RNA 2:376–386.
    OpenUrl
  53. ↵
    1. Takahashi Y,
    2. Hatta H
    (2017) Effects of taurine administration on exercise-induced fatigue and recovery. J Phys Fit Sports Med 6:33–39.
    OpenUrl
  54. ↵
    1. Hansen SH,
    2. Andersen ML,
    3. Cornett C,
    4. Gradinaru R,
    5. Grunnet N
    (2010) A role for taurine in mitochondrial function. J Biomed Sci 17:S23.
    OpenUrlCrossRefPubMed
  55. ↵
    1. Jong CJ,
    2. Azuma J,
    3. Schaffer S
    (2012) Mechanism underlying the antioxidant activity of taurine: Prevention of mitochondrial oxidant production. Amino Acids 42:2223–2232.
    OpenUrlCrossRefPubMed
  56. ↵
    1. Schuller-Levis GB,
    2. Park E
    (2004) Taurine and its chloramine: Modulators of immunity. Neurochem Res 29:117–126.
    OpenUrlCrossRefPubMed
  57. ↵
    1. Dypbukt JM, et al.
    (2005) A sensitive and selective assay for chloramine production by myeloperoxidase. Free Radic Biol Med 39:1468–1477.
    OpenUrlCrossRefPubMed
  58. ↵
    1. Sun Q, et al.
    (2016) Taurine supplementation lowers blood pressure and improves vascular function in prehypertension: Randomized, double-blind, placebo-controlled study. Hypertension 67:541–549.
    OpenUrl
  59. ↵
    1. Yamori Y, et al.
    (2009) Taurine as the nutritional factor for the longevity of the Japanese revealed by a world-wide epidemiological survey. Adv Exp Med Biol 643:13–25.
    OpenUrlCrossRefPubMed
  60. ↵
    1. Xu YJ,
    2. Arneja AS,
    3. Tappia PS,
    4. Dhalla NS
    (2008) The potential health benefits of taurine in cardiovascular disease. Exp Clin Cardiol 13:57–65.
    OpenUrlPubMed
  61. ↵
    1. Li XW,
    2. Gao HY,
    3. Liu J
    (2017) The role of taurine in improving neural stem cells proliferation and differentiation. Nutr Neurosci 20:409–415.
    OpenUrl
  62. ↵
    1. O’Donnell CP, et al.
    (2016) Adjunctive taurine in first-episode psychosis: A phase 2, double-blind, randomized, placebo-controlled study. J Clin Psychiatry 77:e1610–e1617.
    OpenUrl
  63. ↵
    1. Ito T,
    2. Schaffer SW,
    3. Azuma J
    (2012) The potential usefulness of taurine on diabetes mellitus and its complications. Amino Acids 42:1529–1539.
    OpenUrlCrossRefPubMed
  64. ↵
    1. Sarkar P,
    2. Basak P,
    3. Ghosh S,
    4. Kundu M,
    5. Sil PC
    (2017) Prophylactic role of taurine and its derivatives against diabetes mellitus and its related complications. Food Chem Toxicol 110:109–121.
    OpenUrl
  65. ↵
    1. Hansen SH
    (2001) The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev 17:330–346.
    OpenUrlCrossRefPubMed
  66. ↵
    1. Bianchi L, et al.
    (2012) Taurine transporter gene expression in peripheral mononuclear blood cells of type 2 diabetic patients. Amino Acids 42:2267–2274.
    OpenUrlPubMed
  67. ↵
    1. Napoli Z, et al.
    (2016) Taurine transporter gene expression in mononuclear blood cells of type 1 diabetes patients. J Diabetes Res 2016:7313162.
    OpenUrl
  68. ↵
    1. Clark GJ,
    2. Pandya K,
    3. Lau-Cam CA
    (2017) The effect of metformin and taurine, alone and in combination, on the oxidative stress caused by diabetes in the rat brain. Adv Exp Med Biol 975:353–369.
    OpenUrl
  69. ↵
    1. Patel SN,
    2. Lau-Cam CA
    (2017) The effect of taurine and its immediate homologs on diabetes-induced oxidative stress in the brain and spinal cord of rats. Adv Exp Med Biol 975:337–351.
    OpenUrl
  70. ↵
    1. Arany E
    (2017) Maternal taurine supplementation prevents misprogramming. Diet, Nutrition, and Fetal Programming. Nutrition and Health, eds Rajendram R, Preedy V, Patel V (Humana Press, Cham, Switzerland), pp 309–324.
  71. ↵
    1. Schaffer SW,
    2. Jong CJ,
    3. Ramila KC,
    4. Azuma J
    (2010) Physiological roles of taurine in heart and muscle. J Biomed Sci 17:S2.
    OpenUrlCrossRefPubMed
  72. ↵
    1. Kalaras MD,
    2. Richie JP,
    3. Calcagnotto A,
    4. Beelman RB
    (2017) Mushrooms: A rich source of the antioxidants ergothioneine and glutathione. Food Chem 233:429–433.
    OpenUrl
  73. ↵
    1. Seebeck FP
    (2010) In vitro reconstitution of mycobacterial ergothioneine biosynthesis. J Am Chem Soc 132:6632–6633.
    OpenUrlCrossRefPubMed
  74. ↵
    1. Pfeiffer C,
    2. Bauer T,
    3. Surek B,
    4. Schömig E,
    5. Gründemann D
    (2011) Cyanobacteria produce high levels of ergothioneine. Food Chem 129:1766–1769.
    OpenUrlCrossRef
  75. ↵
    1. Ramirez-Martinez A,
    2. Wesolek N,
    3. Yadan J-C,
    4. Moutet M,
    5. Roudot A-C
    (2016) Intake assessment of L-ergothioneine in some european countires and in the United States. Hum Ecol Risk Assess 22:667–677.
    OpenUrl
  76. ↵
    1. Ey J,
    2. Schömig E,
    3. Taubert D
    (2007) Dietary sources and antioxidant effects of ergothioneine. J Agric Food Chem 55:6466–6474.
    OpenUrlCrossRefPubMed
  77. ↵
    1. Hartman PE
    (1990) Ergothioneine as antioxidant. Methods Enzymol 186:310–318.
    OpenUrlCrossRefPubMed
  78. ↵
    1. Franzoni F, et al.
    (2006) An in vitro study on the free radical scavenging capacity of ergothioneine: Comparison with reduced glutathione, uric acid and trolox. Biomed Pharmacother 60:453–457.
    OpenUrlCrossRefPubMed
  79. ↵
    1. Cheah IK,
    2. Tang RM,
    3. Yew TS,
    4. Lim KH,
    5. Halliwell B
    (2017) Administration of pure ergothioneine to healthy human subjects: Uptake, metabolism, and effects on biomarkers of oxidative damage and inflammation. Antioxid Redox Signal 26:193–206.
    OpenUrlCrossRefPubMed
  80. ↵
    1. Servillo L,
    2. DʼOnofrio N,
    3. Balestrieri ML
    (2017) Ergothioneine antioxidant function: From chemistry to cardiovascular therapeutic potential. J Cardiovasc Pharmacol 69:183–191.
    OpenUrl
  81. ↵
    1. Cheah IK,
    2. Feng L,
    3. Tang RMY,
    4. Lim KHC,
    5. Halliwell B
    (2016) Ergothioneine levels in an elderly population decrease with age and incidence of cognitive decline; a risk factor for neurodegeneration? Biochem Biophys Res Commun 478:162–167.
    OpenUrl
  82. ↵
    1. Halliwell B,
    2. Cheah IK,
    3. Drum CL
    (2016) Ergothioneine, an adaptive antioxidant for the protection of injured tissues? A hypothesis. Biochem Biophys Res Commun 470:245–250.
    OpenUrl
  83. ↵
    1. Taubert D, et al.
    (2006) Association of rheumatoid arthritis with ergothioneine levels in red blood cells: A case control study. J Rheumatol 33:2139–2145.
    OpenUrlAbstract/FREE Full Text
  84. ↵
    1. Paul BD,
    2. Snyder SH
    (2010) The unusual amino acid L-ergothioneine is a physiologic cytoprotectant. Cell Death Differ 17:1134–1140.
    OpenUrlCrossRefPubMed
  85. ↵
    1. Gründemann D, et al.
    (2005) Discovery of the ergothioneine transporter. Proc Natl Acad Sci USA 102:5256–5261.
    OpenUrlAbstract/FREE Full Text
  86. ↵
    1. Gründemann D
    (2012) The ergothioneine transporter controls and indicates ergothioneine activity—A review. Prev Med 54:S71–S74.
    OpenUrlCrossRefPubMed
  87. ↵
    1. Mathieson I, et al.
    (2015) Genome-wide patterns of selection in 230 ancient Eurasians. Nature 528:499–503.
    OpenUrlCrossRefPubMed
  88. ↵
    1. Peltekova VD, et al.
    (2004) Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36:471–475.
    OpenUrlCrossRefPubMed
  89. ↵
    1. Jung ES,
    2. Park HJ,
    3. Kong KA,
    4. Choi JH,
    5. Cheon JH
    (2017) Association study between OCTN1 functional haplotypes and Crohn’s disease in a Korean population. Korean J Physiol Pharmacol 21:11–17.
    OpenUrl
  90. ↵
    1. Kato Y, et al.
    (2010) Gene knockout and metabolome analysis of carnitine/organic cation transporter OCTN1. Pharm Res 27:832–840.
    OpenUrlCrossRefPubMed
  91. ↵
    1. Pfeiffer C, et al.
    (2015) Knockout of the ergothioneine transporter ETT in zebrafish results in increased 8-oxoguanine levels. Free Radic Biol Med 83:178–185.
    OpenUrl
  92. ↵
    1. Rucker R,
    2. Chowanadisai W,
    3. Nakano M
    (2009) Potential physiological importance of pyrroloquinoline quinone. Altern Med Rev 14:268–277.
    OpenUrlPubMed
  93. ↵
    1. Klinman JP,
    2. Bonnot F
    (2014) Intrigues and intricacies of the biosynthetic pathways for the enzymatic quinocofactors: PQQ, TTQ, CTQ, TPQ, and LTQ. Chem Rev 114:4343–4365.
    OpenUrlCrossRefPubMed
  94. ↵
    1. Kumazawa T,
    2. Sato K,
    3. Seno H,
    4. Ishii A,
    5. Suzuki O
    (1995) Levels of pyrroloquinoline quinone in various foods. Biochem J 307:331–333.
    OpenUrlAbstract/FREE Full Text
  95. ↵
    1. Choi O, et al.
    (2008) Pyrroloquinoline quinone is a plant growth promotion factor produced by Pseudomonas fluorescens B16. Plant Physiol 146:657–668.
    OpenUrlAbstract/FREE Full Text
  96. ↵
    1. Itoh Y, et al.
    (2016) Effect of the antioxidant supplement pyrroloquinoline quinone disodium salt (BioPQQ™) on cognitive functions. Adv Exp Med Biol 876:319–325.
    OpenUrl
  97. ↵
    1. Harris CB, et al.
    (2013) Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects. J Nutr Biochem 24:2076–2084.
    OpenUrlCrossRefPubMed
  98. ↵
    1. Akagawa M, et al.
    (2016) Identification of lactate dehydrogenase as a mammalian pyrroloquinoline quinone (PQQ)-binding protein. Sci Rep 6:26723.
    OpenUrl
  99. ↵
    1. Stites T, et al.
    (2006) Pyrroloquinoline quinone modulates mitochondrial quantity and function in mice. J Nutr 136:390–396.
    OpenUrlAbstract/FREE Full Text
  100. ↵
    1. Chowanadisai W, et al.
    (2010) Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expression. J Biol Chem 285:142–152.
    OpenUrlAbstract/FREE Full Text
  101. ↵
    1. Nishimura S
    (1983) Structure, biosynthesis, and function of queuosine in transfer RNA. Prog Nucleic Acid Res Mol Biol 28:49–73.
    OpenUrlCrossRefPubMed
  102. ↵
    1. Fergus C,
    2. Barnes D,
    3. Alqasem MA,
    4. Kelly VP
    (2015) The queuine micronutrient: Charting a course from microbe to man. Nutrients 7:2897–2929.
    OpenUrlCrossRefPubMed
  103. ↵
    1. Farkas WR
    (1980) Effect of diet on the queuosine family of tRNAs of germ-free mice. J Biol Chem 255:6832–6835.
    OpenUrlAbstract/FREE Full Text
  104. ↵
    1. Reyniers JP,
    2. Pleasants JR,
    3. Wostmann BS,
    4. Katze JR,
    5. Farkas WR
    (1981) Administration of exogenous queuine is essential for the biosynthesis of the queuosine-containing transfer RNAs in the mouse. J Biol Chem 256:11591–11594.
    OpenUrlAbstract/FREE Full Text
  105. ↵
    1. Boland C,
    2. Hayes P,
    3. Santa-Maria I,
    4. Nishimura S,
    5. Kelly VP
    (2009) Queuosine formation in eukaryotic tRNA occurs via a mitochondria-localized heteromeric transglycosylase. J Biol Chem 284:18218–18227.
    OpenUrlAbstract/FREE Full Text
  106. ↵
    1. Rakovich T, et al.
    (2011) Queuosine deficiency in eukaryotes compromises tyrosine production through increased tetrahydrobiopterin oxidation. J Biol Chem 286:19354–19363.
    OpenUrlAbstract/FREE Full Text
  107. ↵
    1. Watschinger K, et al.
    (2015) Tetrahydrobiopterin and alkylglycerol monooxygenase substantially alter the murine macrophage lipidome. Proc Natl Acad Sci USA 112:2431–2436.
    OpenUrlAbstract/FREE Full Text
  108. ↵
    1. Alrayes N, et al.
    (2016) The alkylglycerol monooxygenase (AGMO) gene previously involved in autism also causes a novel syndromic form of primary microcephaly in a consanguineous Saudi family. J Neurol Sci 363:240–244.
    OpenUrl
  109. ↵
    1. Frye RE
    (2014) Tetrahydrobiopterin deficiency in autism spectrum disorder. N Am J Med Sci (Boston) 7:93–96.
    OpenUrl
  110. ↵
    1. Burton B, et al.
    (2015) A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria. Mol Genet Metab 114:415–424.
    OpenUrl
  111. ↵
    1. Frye RE
    (2015) Metabolic and mitochondrial disorders associated with epilepsy in children with autism spectrum disorder. Epilepsy Behav 47:147–157.
    OpenUrl
  112. ↵
    1. Marks T,
    2. Farkas WR
    (1997) Effects of a diet deficient in tyrosine and queuine on germfree mice. Biochem Biophys Res Commun 230:233–237.
    OpenUrlCrossRefPubMed
  113. ↵
    1. Varghese S, et al.
    (2017) In vivo modification of tRNA with an artificial nucleobase leads to full disease remission in an animal model of multiple sclerosis. Nucleic Acids Res 45:2029–2039.
    OpenUrl
  114. ↵
    1. Klotz LO,
    2. Kröncke KD,
    3. Sies H
    (2003) Singlet oxygen-induced signaling effects in mammalian cells. Photochem Photobiol Sci 2:88–94.
    OpenUrlCrossRefPubMed
  115. ↵
    1. Institute of Medicine
    (2000) Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids (National Academy Press, Washington, DC).
  116. ↵
    1. Scott-Boyer MP, et al.
    (2016) A network analysis of cofactor-protein interactions for analyzing associations between human nutrition and diseases. Sci Rep 6:19633.
    OpenUrl
  117. ↵
    1. Blumberg JB,
    2. Bailey RL,
    3. Sesso HD,
    4. Ulrich CM
    (2018) The evolving role of multivitamin/multimineral supplement use among adults in the age of personalized nutrition. Nutrients 10:E248.
    OpenUrl
  118. ↵
    1. Lim SS, et al.
    (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2224–2260.
    OpenUrlCrossRefPubMed
  119. ↵
    1. Bao Y, et al.
    (2013) Association of nut consumption with total and cause-specific mortality. N Engl J Med 369:2001–2011.
    OpenUrlCrossRefPubMed
  120. ↵
    1. Micha R, et al.
    (2017) Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States. JAMA 317:912–924.
    OpenUrlCrossRefPubMed
  121. ↵
    1. Schwingshackl L, et al.
    (2017) Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: A systematic review and meta-analysis of primary prevention trials. Adv Nutr 8:27–39.
    OpenUrlAbstract/FREE Full Text
  122. ↵
    1. Shlisky J, et al.
    (2017) Nutritional considerations for healthy aging and reduction in age-related chronic disease. Adv Nutr 8:17–26.
    OpenUrlAbstract
  123. ↵
    1. Ewald P
    (2002) Plague Time: The New Gem Theory of Disease (Anchor Books, New York).
  124. ↵
    1. Bourke CD,
    2. Berkley JA,
    3. Prendergast AJ
    (2016) Immune dysfunction as a cause and consequence of malnutrition. Trends Immunol 37:386–398.
    OpenUrlCrossRefPubMed
  125. ↵
    1. García OP,
    2. Long KZ,
    3. Rosado JL
    (2009) Impact of micronutrient deficiencies on obesity. Nutr Rev 67:559–572.
    OpenUrlCrossRefPubMed
  126. ↵
    1. Damms-Machado A,
    2. Weser G,
    3. Bischoff SC
    (2012) Micronutrient deficiency in obese subjects undergoing low calorie diet. Nutr J 11:34.
    OpenUrlCrossRefPubMed
  127. ↵
    1. Via M
    (2012) The malnutrition of obesity: Micronutrient deficiencies that promote diabetes. ISRN Endocrinol 2012:103472.
    OpenUrlCrossRefPubMed
  128. ↵
    1. Amara NB, et al.
    (2014) Multivitamin restriction increases adiposity and disrupts glucose homeostasis in mice. Genes Nutr 9:410.
    OpenUrl
  129. ↵
    1. Agarwal S,
    2. Reider C,
    3. Brooks JR,
    4. Fulgoni VL 3rd
    (2015) Comparison of prevalence of inadequate nutrient intake based on body weight status of adults in the United States: An analysis of NHANES 2001-2008. J Am Coll Nutr 34:126–134.
    OpenUrlCrossRefPubMed
  130. ↵
    1. McCann JC, et al.
    (2015) A multicomponent nutrient bar promotes weight loss and improves dyslipidemia and insulin resistance in the overweight/obese: Chronic inflammation blunts these improvements. FASEB J 29:3287–3301.
    OpenUrlCrossRefPubMed
  131. ↵
    1. Arnold M,
    2. Renehan AG,
    3. Colditz GA
    (2017) Excess weight as a risk factor common to many cancer sites: Words of caution when interpreting meta-analytic evidence. Cancer Epidemiol Biomarkers Prev 26:663–665.
    OpenUrlFREE Full Text
  132. ↵
    1. Ajala O,
    2. Mold F,
    3. Boughton C,
    4. Cooke D,
    5. Whyte M
    (2017) Childhood predictors of cardiovascular disease in adulthood. A systematic review and meta-analysis. Obes Rev 18:1061–1070.
    OpenUrlPubMed
  133. ↵
    1. Caleyachetty R, et al.
    (2017) Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women. J Am Coll Cardiol 70:1429–1437.
    OpenUrlFREE Full Text
  134. ↵
    1. Lassale C, et al.
    (2017) Separate and combined associations of obesity and metabolic health with coronary heart disease: A pan-European case-cohort analysis. Eur Heart J 39:397–406.
    OpenUrl
  135. ↵
    1. McIntyre RS, et al.
    (2017) Adverse effects of obesity on cognitive functions in individuals at ultra high risk for bipolar disorder: Results from the global mood and brain science initiative. Bipolar Disord 19:128–134.
    OpenUrl
  136. ↵
    1. Rhea EM, et al.
    (2017) Blood-brain barriers in obesity. AAPS J 19:921–930.
    OpenUrl
  137. ↵
    1. Stillman CM,
    2. Weinstein AM,
    3. Marsland AL,
    4. Gianaros PJ,
    5. Erickson KI
    (2017) Body-brain connections: The effects of obesity and behavioral interventions on neurocognitive aging. Front Aging Neurosci 9:115.
    OpenUrl
  138. ↵
    1. Saltiel AR,
    2. Olefsky JM
    (2017) Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest 127:1–4.
    OpenUrlCrossRefPubMed
  139. ↵
    1. Gonzales GB, et al.
    (2015) Flavonoid interactions during digestion, absorption, distribution and metabolism: A sequential structure-activity/property relationship-based approach in the study of bioavailability and bioactivity. Drug Metab Rev 47:175–190.
    OpenUrl
  140. ↵
    1. Ames BN,
    2. Profet M,
    3. Gold LS
    (1990) Dietary pesticides (99.99% all natural). Proc Natl Acad Sci USA 87:7777–7781.
    OpenUrlAbstract/FREE Full Text
  141. ↵
    1. Saul N,
    2. Pietsch K,
    3. Stürzenbaum SR,
    4. Menzel R,
    5. Steinberg CE
    (2013) Hormesis and longevity with tannins: Free of charge or cost-intensive? Chemosphere 93:1005–1008.
    OpenUrl
  142. ↵
    1. Nelson JW,
    2. Breaker RR
    (2017) The lost language of the RNA world. Sci Signal 10:eaam8812.
    OpenUrlAbstract/FREE Full Text
  143. ↵
    1. Ames BN,
    2. Elson-Schwab I,
    3. Silver EA
    (2002) High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): Relevance to genetic disease and polymorphisms. Am J Clin Nutr 75:616–658.
    OpenUrlAbstract/FREE Full Text
  144. ↵
    1. Kaput J,
    2. Rodriguez R
    1. Ames BN,
    2. Suh JH,
    3. Liu J
    (2006) Enzymes lose binding affinity (increase Km) for coenzymes and substrates with age: A strategy for remediation. Nutrigenomics: Discovering the Path to Personalized Nutrition, eds Kaput J, Rodriguez R (John Wiley & Sons, Hoboken, NJ), pp 277–293.
  145. ↵
    1. Liu J,
    2. Atamna H,
    3. Kuratsune H,
    4. Ames BN
    (2002) Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Ann N Y Acad Sci 959:133–166.
    OpenUrlPubMed
  146. ↵
    1. Höller U, et al.
    (2018) Micronutrient status assessment in humans: Current methods of analysis and future trends. Trends Analyt Chem 102:110–122.
    OpenUrl
  147. ↵
    1. Food Supplements Europe
    (2017) Healthcare cost savings of calcium and vitamin D food supplements in the European Union (Frost & Sullivan, Mountain View, CA).
  148. ↵
    1. Willett WC
    (2013) Nutritional Epidemiology (Oxford Univ Press, New York), 3rd Ed.
PreviousNext
Back to top
Article Alerts
Email Article

Thank you for your interest in spreading the word on PNAS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prolonging healthy aging: Longevity vitamins and proteins
(Your Name) has sent you a message from PNAS
(Your Name) thought you would like to see the PNAS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Prolonging healthy aging: Longevity vitamins and proteins
Bruce N. Ames
Proceedings of the National Academy of Sciences Oct 2018, 115 (43) 10836-10844; DOI: 10.1073/pnas.1809045115

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Prolonging healthy aging: Longevity vitamins and proteins
Bruce N. Ames
Proceedings of the National Academy of Sciences Oct 2018, 115 (43) 10836-10844; DOI: 10.1073/pnas.1809045115
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Mendeley logo Mendeley

Article Classifications

  • Biological Sciences
  • Medical Sciences
Proceedings of the National Academy of Sciences: 115 (43)
Table of Contents

Submit

Sign up for Article Alerts

Jump to section

  • Article
    • Abstract
    • Deficiencies in Vitamins and Minerals
    • Triage Theory
    • Rethinking Vitamins: Longevity Proteins and Vitamins
    • Survival V/M That Are also Longevity V/M
    • Conditional Vitamins
    • Putative Longevity Vitamins: Ergothionine, Pyrroloquinoline Quinone, Queuine, Carotenoids
    • Discussion
    • The Future
    • Acknowledgments
    • Footnotes
    • References
  • Figures & SI
  • Info & Metrics
  • PDF

You May Also be Interested in

Water from a faucet fills a glass.
News Feature: How “forever chemicals” might impair the immune system
Researchers are exploring whether these ubiquitous fluorinated molecules might worsen infections or hamper vaccine effectiveness.
Image credit: Shutterstock/Dmitry Naumov.
Reflection of clouds in the still waters of Mono Lake in California.
Inner Workings: Making headway with the mysteries of life’s origins
Recent experiments and simulations are starting to answer some fundamental questions about how life came to be.
Image credit: Shutterstock/Radoslaw Lecyk.
Cave in coastal Kenya with tree growing in the middle.
Journal Club: Small, sharp blades mark shift from Middle to Later Stone Age in coastal Kenya
Archaeologists have long tried to define the transition between the two time periods.
Image credit: Ceri Shipton.
Illustration of groups of people chatting
Exploring the length of human conversations
Adam Mastroianni and Daniel Gilbert explore why conversations almost never end when people want them to.
Listen
Past PodcastsSubscribe
Panda bear hanging in a tree
How horse manure helps giant pandas tolerate cold
A study finds that giant pandas roll in horse manure to increase their cold tolerance.
Image credit: Fuwen Wei.

Similar Articles

Site Logo
Powered by HighWire
  • Submit Manuscript
  • Twitter
  • Facebook
  • RSS Feeds
  • Email Alerts

Articles

  • Current Issue
  • Special Feature Articles – Most Recent
  • List of Issues

PNAS Portals

  • Anthropology
  • Chemistry
  • Classics
  • Front Matter
  • Physics
  • Sustainability Science
  • Teaching Resources

Information

  • Authors
  • Editorial Board
  • Reviewers
  • Subscribers
  • Librarians
  • Press
  • Cozzarelli Prize
  • Site Map
  • PNAS Updates
  • FAQs
  • Accessibility Statement
  • Rights & Permissions
  • About
  • Contact

Feedback    Privacy/Legal

Copyright © 2021 National Academy of Sciences. Online ISSN 1091-6490